Ivan Leo Pinto

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 49(Granted Patents)

Location History:

Sutton, GB (2002)
Harlow, GB (2003 - 2012)
Stevenage, GB (2006 - 2013)
Essex, GB (2014 - 2016)

Company Filing History:

9 out of 2,198

Smithkline Beecham Corporation

Years Active: 2002-2016

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9266841 - Compounds (2016-02-23),

2. 8871775 - Compounds (2014-10-28),

3. 8394808 - HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes (2013-03-12),

4. 8268839 - Compounds (2012-09-18),

5. 8143264 - Xanthine derivatives as selective HM74A agonists (2012-03-27),

6. 7713982 - Xanthines with HM74A receptor activity (2010-05-11),

7. 7652019 - 5,6-trimethylenepyrimidin-4-one compounds (2010-01-26),

8. 7638520 - Pyrimidine compounds (2009-12-29),

9. 7462620 - Pyrimidinone derivatives and their use in the treatment of atherosclerosis (2008-12-09),

10. 7235566 - Pyridinone derivatives for treatment of atherosclerosis (2007-06-26),

11. 7169924 - Pyrimidinone derivatives and their use in the treatment of atherosclerosis (2007-01-30),

12. 7115616 - Pyrimidinone compounds (2006-10-03),

13. 6649619 - Compounds (2003-11-18),

14. 6417192 - Pyrimidinone compounds and pharmaceutical compositions containing them (2002-07-09),

Title: An Overview of Inventor Ivan Leo Pinto

Introduction

Ivan Leo Pinto, based in Stevenage, GB, is a distinguished inventor with a notable portfolio of 14 patents. His work primarily focuses on pharmaceutical compounds with significant therapeutic implications.

Latest Patents

Among his most recent innovations are Pyrimidone compounds of formula (I), which serve as inhibitors of the enzyme Lp-PLA. These compounds are particularly promising in the treatment of atherosclerosis, showcasing his contribution to medicine and healthcare innovation.

Career Highlights

Ivan has had a fruitful career, contributing his expertise to prominent companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His work in these organizations has played a crucial role in advancing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Ivan Leo Pinto has collaborated with notable individuals, including Deirdre Mary Bernadette Hickey and Colin Andrew Leach. These collaborations have contributed to the successful development of his patented inventions and have helped solidify his reputation in the industry.

Conclusion

Ivan Leo Pinto's innovative contributions, particularly in the development of therapeutic compounds, underline his significance as an inventor in the field of healthcare. With a strong track record and continued contributions to notable organizations, he remains a pivotal figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.